002172.SZ
澳洋健康
SZSE · Basic Materials · Q 卫生 · CN
CNY 4.44
+9.90%Year over year
Reported trailing growth
- Revenue
- -6.3%
- EBITDA
- —
- EBIT
- -11.0%
- EPS
- +19.0%
- Free cash flow
- +370.4%
- Operating cash flow
- +590.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -3.7%
- EBITDA
- +14.2%
- EBIT
- +97.7%
- Net income
- -8.8%
- EPS
- -8.7%
- Free cash flow
- +29.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026